News New paediatric use for Allergan's biosimilar-threatened Boto... Allergan’s Botox has another clinical use after the FDA granted approval for children with upper limb spasticity.
News FDA approves Herceptin biosimilar as US patent expires The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry.
News SMC approves medicines for breast cancer, skin cancer, schiz... The Scottish Medicines Consortium (SM
Views & Analysis Collaborating to fight NASH Eric Hughes, Global Development Unit head at Novartis for Immunology, Hepatology & Dermatology, believes that collaboration is going to be key to finally finding a treatment for non
News Discontent at Allergan over CEO's chairman role - report There is discontent among Allergan’s shareholders over CEO Brent Saunders’ dual role as chairman, according to press reports.
News Lilly's 'triple G' retatrutide aces crucial obesity trial Lilly's retatrutide achieved weight loss of more than 30% at two years in a new trial, firming up its credentials as a next-generation obesity drug.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
